About
Therapeutic Peptides
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapySeattle/Pacific Northwest
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
1,155
By Phase
PHASE1: 1PHASE2/PHASE3: 1PHASE1/PHASE2: 2
By Status
COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04855565Lead Sponsor
ALY688-SR in Generally Healthy Overweight or Obese Adults
PHASE1Terminated
8 participants
Started: May 19, 2021 · Completed: Aug 3, 2021
NCT04899518Lead Sponsor
ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
PHASE2/PHASE3Completed
922 participants
Started: May 19, 2021 · Completed: Mar 14, 2023
NCT04201574Lead Sponsor
Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
PHASE1/PHASE2Completed
138 participants
Started: Dec 16, 2019 · Completed: Sep 15, 2020
NCT03452033Lead Sponsor
H-1337 Ophthalmic Solution Phase 1/2
PHASE1/PHASE2Completed
87 participants
Started: Mar 15, 2018 · Completed: Aug 15, 2018
Locations (1)
Headquarters
Bellevue, WA, United States
Map
Loading map...